Elekta AB (publ)

OM:EKTA B Stock Report

Market Cap: SEK 19.7b

Elekta Valuation

Is EKTA B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of EKTA B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: EKTA B (SEK51.6) is trading below our estimate of future cash flow value (SEK94.01)

Significantly Below Future Cash Flow Value: EKTA B is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EKTA B?

Key metric: As EKTA B is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for EKTA B. This is calculated by dividing EKTA B's market cap by their current revenue.
What is EKTA B's PS Ratio?
PS Ratio1.2x
SalesSEK 16.72b
Market CapSEK 19.72b

Price to Sales Ratio vs Peers

How does EKTA B's PS Ratio compare to its peers?

The above table shows the PS ratio for EKTA B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.1x
GETI B Getinge
1.6x4.40%SEK 53.1b
ARJO B Arjo
0.6x3.43%SEK 6.5b
CEVI CellaVision
4.7x8.81%SEK 3.4b
SUS Surgical Science Sweden
1.6x10.21%SEK 1.6b
EKTA B Elekta
1.2x4.32%SEK 19.7b

Price-To-Sales vs Peers: EKTA B is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (2.1x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does EKTA B's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

13 CompaniesPrice / SalesEstimated GrowthMarket Cap
ARJO B Arjo
0.6x3.43%US$698.41m
ADDV A ADDvise Group
0.6x3.82%US$115.93m
CARE Careium
0.7x6.75%US$63.88m
BOUL Boule Diagnostics
0.3x3.89%US$13.72m
EKTA B 1.2xIndustry Avg. 3.9xNo. of Companies13PS048121620+
13 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: EKTA B is good value based on its Price-To-Sales Ratio (1.2x) compared to the Swedish Medical Equipment industry average (3.9x).

Price to Sales Ratio vs Fair Ratio

What is EKTA B's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EKTA B PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ratio1.6x

Price-To-Sales vs Fair Ratio: EKTA B is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (1.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EKTA B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 51.60
SEK 60.50
+17.25%
26.52%SEK 100.00SEK 41.00n/a15
Jun ’27SEK 52.65
SEK 60.50
+14.91%
26.52%SEK 100.00SEK 41.00n/a15
May ’27SEK 53.25
SEK 60.40
+13.43%
27.67%SEK 100.00SEK 39.00n/a15
Apr ’27SEK 55.90
SEK 60.25
+7.78%
26.97%SEK 100.00SEK 39.00n/a16
Mar ’27SEK 58.05
SEK 56.07
-3.41%
29.64%SEK 108.00SEK 39.00n/a14
Feb ’27SEK 57.20
SEK 55.79
-2.47%
29.41%SEK 108.00SEK 39.00n/a14
Jan ’27SEK 56.75
SEK 56.15
-1.05%
30.22%SEK 108.00SEK 39.00n/a13
Dec ’26SEK 56.45
SEK 56.77
+0.57%
29.95%SEK 108.00SEK 39.00n/a13
Nov ’26SEK 48.34
SEK 53.60
+10.88%
31.80%SEK 108.00SEK 34.00n/a13
Oct ’26SEK 47.26
SEK 53.69
+13.61%
31.69%SEK 108.00SEK 34.00n/a13
Sep ’26SEK 47.96
SEK 55.31
+15.32%
28.99%SEK 108.00SEK 39.00n/a13
Aug ’26SEK 46.82
SEK 58.58
+25.11%
27.38%SEK 108.00SEK 39.00n/a13
Jul ’26SEK 49.08
SEK 58.58
+19.35%
27.38%SEK 108.00SEK 39.00n/a13
Jun ’26SEK 50.50
SEK 62.15
+23.08%
23.83%SEK 108.00SEK 47.00SEK 52.6513
May ’26SEK 49.00
SEK 67.07
+36.88%
21.04%SEK 108.00SEK 51.50SEK 53.2514
Apr ’26SEK 53.60
SEK 67.07
+25.13%
21.04%SEK 108.00SEK 51.50SEK 55.9014
Mar ’26SEK 59.05
SEK 69.86
+18.30%
27.36%SEK 127.00SEK 51.50SEK 58.0514
Feb ’26SEK 65.75
SEK 73.31
+11.49%
26.54%SEK 127.00SEK 51.50SEK 57.2013
Jan ’26SEK 61.15
SEK 73.38
+20.01%
27.12%SEK 127.00SEK 51.50SEK 56.7513
Dec ’25SEK 65.05
SEK 74.12
+13.94%
25.95%SEK 127.00SEK 57.00SEK 56.4513
Nov ’25SEK 64.30
SEK 76.36
+18.75%
23.64%SEK 127.00SEK 57.00SEK 48.3414
Oct ’25SEK 70.00
SEK 76.21
+8.88%
23.82%SEK 127.00SEK 57.00SEK 47.2614
Sep ’25SEK 70.10
SEK 76.69
+9.40%
24.66%SEK 127.00SEK 57.00SEK 47.9613
Aug ’25SEK 66.40
SEK 76.31
+14.92%
24.95%SEK 127.00SEK 57.00SEK 46.8213
Jul ’25SEK 65.90
SEK 76.38
+15.91%
24.74%SEK 127.00SEK 57.00SEK 49.0813
Jun ’25SEK 86.15
SEK 84.08
-2.40%
24.36%SEK 127.00SEK 57.00SEK 50.5012
SEK 60.5
Fair Value
14.7% undervalued intrinsic discount
15
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 04:42
End of Day Share Price 2026/06/16 00:00
Earnings2026/04/30
Annual Earnings2026/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elekta AB (publ) is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Alexander KlebanBarclays
Sally TaylorBarclays